Results 101 to 110 of about 39,145 (192)

Oncogenic GPRIN1 sustains proliferation and mitochondrial homeostasis via dual‑layer CDK1-PI3K/Akt signalling in gallbladder cancer. [PDF]

Cell Death Dis
Xu C, Gong Z, Ni X, Nan L, Sun W, Liu H, Luo X, Li M.   +7 more
europepmc   +1 more source

Targeting FN1 to overcome gemcitabine resistance in gallbladder cancer: Mechanistic insights and an iRGD-modified PEG-PLGA nanoparticle delivery strategy. [PDF]

Mater Today Bio
Tian M, Meng X, Song W, Wu Z, Liu Y, Dong X, Ren S, Du J, Zhao P.   +8 more
europepmc   +1 more source

Targeting E2F8 sensitizes gemcitabine-resistant gallbladder cancer to PARP inhibitors by disrupting RRM2-driven DNA repair. [PDF]

J Exp Clin Cancer Res
Ni X, Li M, Qiu W, Han J, Yu M, Zhang S, Zheng B, He J, Liu H.   +8 more
europepmc   +1 more source

Final International Congress “Noz Num”

, 2022
openaire   +2 more sources

Impacts of Intensified Heatwaves on Escalation of Ozone and Reactive Nitrogen in Summer. [PDF]

Environ Sci Technol
Wang N, Duan F, Shan L, Zhang S, Ma Y, Zhang Q, Zhu L, Wang S, Jiang J, Huang T, Kimoto T, He K.   +11 more
europepmc   +1 more source

Novel mechanism of tumor metastasis: DDX11-ATAD5 interaction mediates epithelial-mesenchymal transition to promote gallbladder cancer progression. [PDF]

Cytojournal
Kong L, Li W, Kong W, Yang H.
europepmc   +1 more source

OLFM4 orchestrates the immunosuppressive microenvironment and drives gallbladder cancer progression. [PDF]

J Cancer Res Clin Oncol
Li W, Liu K, Yang F, He H, Wen W.
europepmc   +1 more source

Identification and verification of the key genes involved in gallbladder cancer. [PDF]

Front Immunol
Tang J, Zhou H, Lu M, Cao D, Zhang Y, Zhou S.   +5 more
europepmc   +1 more source

Decreased Endothelin-1 bioavailability impairs aggressiveness of gallbladder cancer cells. [PDF]

Biol Res
Vidal-Vidal J, Brown-Brown D, Quilaqueo-Millaqueo N, Peña-Münzenmayer G, Spichiger C, Quezada-Monrás C, Salazar-Onfray F, Tapia JC, Niechi I.   +8 more
europepmc   +1 more source

MicroRNA-451a inhibits gemcitabine-refractory biliary tract cancer progression by suppressing the MIF-mediated PI3K/AKT pathway. [PDF]

Mol Ther Nucleic Acids, 2023
Obata T, Tsutsumi K, Ueta E, Oda T, Kikuchi T, Ako S, Fujii Y, Yamazaki T, Uchida D, Matsumoto K, Horiguchi S, Kato H, Okada H, Otsuka M.   +13 more
europepmc   +1 more source